Show simple item record

dc.creatorGallardo E,Jorge
dc.creatorCabrera A,Elsa
dc.creatorRubio L,Betzabé
dc.creatorGonzález V,Carolina
dc.creatorCortés A,Claudio
dc.date2001-08-01
dc.date.accessioned2019-11-14T12:52:37Z
dc.date.available2019-11-14T12:52:37Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000800010
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/115497
dc.descriptionCholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival (Rev Méd Chile 2001; 911-6).
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98872001000800010
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.129 n.8 2001
dc.subjectCholangiocarcinoma
dc.subjectCholangiography
dc.subjectGemcitabine
dc.titleGemcitabina en 4 pacientes con colangiocarcinoma: Report of four cases


This item appears in the following Collection(s)

Show simple item record